Atlas Trials

the Safety and Efficacy of Antiplatelet Therapy in Patients of CAA

Clinical trial NCT04654026 · UNKNOWN

Trial details

NCT number
NCT04654026
Sponsor
Shenzhen Second People's Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Cerebral Amyloid Angiopathy
Start date
2021-02-20
Primary completion
2022-12-30
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.